We are live on ! Find out more
MC

Merck & Co Portfolio holdings

AUM $349M
1-Year Est. Return 146.07%
This Fund
S&P 500
This Quarter Est. Return
+45.19%
1 Year Est. Return
+146.07%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$51.3M
Cap. Flow
+$47.1K
Cap. Flow %
0.02%
Top 10 Hldgs %
99.68%
Holding
13
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HURA
TuHURA Biosciences
HURA
+$47.1K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
1
Personalis
PSNL
$1.39B
$92.1M 42.73%
14,044,943
– –
MRNA icon
2
Moderna
MRNA
$21.5B
$63.7M 29.54%
2,308,190
– –
KYMR icon
3
Kymera Therapeutics
KYMR
$8.75B
$33.7M 15.63%
772,165
– –
TRDA icon
4
Entrada Therapeutics
TRDA
$267M
$11.7M 5.42%
1,739,768
– –
ALEC icon
5
Alector
ALEC
$203M
$4.96M 2.3%
3,545,719
– –
EVAX
6
Evaxion A/S
EVAX
$25M
$2.97M 1.38%
1,214,126
– –
STRO icon
7
Sutro Biopharma
STRO
$400M
$1.94M 0.9%
272,351
– –
LVTX
8
DELISTED
LAVA Therapeutics
LVTX
$1.52M 0.7%
1,149,345
– –
VRDN icon
9
Viridian Therapeutics
VRDN
$2.49B
$1.31M 0.61%
93,414
– –
XLO icon
10
Xilio Therapeutics
XLO
$61M
$1.01M 0.47%
105,983
– –
CARM
11
DELISTED
Carisma Therapeutics
CARM
$577K 0.27%
1,473,240
– –
NEUP
12
Neuphoria Therapeutics
NEUP
$21.1M
$71.2K 0.03%
10,027
– –
HURA
13
TuHURA Biosciences
HURA
$135M
$31.1K 0.01%
+13,950
New +$47.1K

Similar funds

KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EPW
Endeavor Private Wealth Topeka, Kansas $349M AUM 16.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM

Merck & Co's Q2 2025 Portfolio in Review

As of Q2 2025, Merck & Co held 13 positions worth $216M, up 31% from $164M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Merck & Co's Q2 2025 filing shows 1 new position. Its largest new stake was TuHURA Biosciences: 13,950 shares worth $31.1K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Merck & Co's largest Q2 2025 buy was TuHURA Biosciences: 13,950 shares worth $31.1K.
  • Merck & Co's ten largest holdings make up 100% of its $216M portfolio in Q2 2025.
  • Merck & Co opened 1 new position and closed 0 in Q2 2025.
  • Merck & Co's portfolio value rose 31% quarter-over-quarter to $216M.

Based on Merck & Co's 13F filing for Q2 2025, filed 13 Aug 2025.